Strong Revenue Growth
Total revenue increased by 33% to $28.3 million in fiscal year 2024 compared to $21.3 million in fiscal year 2023. This growth was driven by the acquisition of Rhode Island radiation therapy operations and the launch of operations in Puebla, Mexico.
Direct Patient Services Segment Surge
Revenue from direct patient services was $12.6 million for fiscal year 2024, marking an increase of 253% compared to fiscal year 2023. This growth was primarily driven by the acquisition of the Rhode Island centers.
Net Income Increase
Net income attributable to American Shared Hospital Services for fiscal year 2024 increased 258% to $2.2 million or $0.33 per diluted share compared to $610,000 or $0.10 per diluted share for fiscal year 2023.
International Expansion
AMS established its fourth international center with a joint venture agreement for a Gamma Knife center in Guadalajara, Mexico, and expects stronger international growth from additional treatment volumes in Ecuador, Peru, and new centers in Mexico.
Leadership Transition
Gary Delanois was appointed as CEO, bringing extensive experience in healthcare operations and financial management to lead AMS into its next phase of expansion and innovation.